4-Year RCT Tests Brain Training and Exercise to Slow Cognitive Aging in Older Adults
A Malaysian RCT targets 400 adults aged 60+ with cognitive stimulation and physical activity to slow brain aging over four years.
Summary
Researchers in Malaysia have launched a rigorous four-year randomized controlled trial testing whether cognitive stimulation, physical activity, or their combination can slow age-related cognitive and brain decline in 400 community-dwelling adults aged 60 and older. Unlike most aging studies focused on Western populations, this trial is designed for multiethnic Asian communities and aims to address the cultural and educational gaps in Western-designed psychometric tools. Outcomes span cognitive scores, brain imaging (EEG and MRI), salivary biomarkers including telomere length, C-reactive protein, and lactoferrin, decision-making tasks, and a cost-benefit economic analysis. The multidisciplinary approach integrates psychology, neuroscience, biology, and economics. Recruitment ran from May 2022 to July 2023, the intervention phase is ongoing, and the first outcome publications are anticipated in 2026.
Detailed Summary
Population aging is accelerating globally, yet longer lives are not automatically healthier ones. A critical challenge is maintaining cognitive independence in older adults, since cognitive decline drives loss of autonomy, increased caregiver burden, and reduced workforce productivity. Most evidence guiding interventions has come from Western populations, leaving significant gaps for the ethnically and culturally diverse populations of Asia — a gap compounded by reliance on Western-designed psychometric instruments that may not capture cognitive health accurately across cultural and educational contexts.
This paper describes the protocol for a four-year randomized controlled trial conducted in Malaysia enrolling 400 community-dwelling adults aged 60 and older. Participants are randomized into three active intervention arms — cognitive stimulation alone, physical activity alone, or a combined program — and compared against a control group. Recruitment ran from May 2022 to July 2023, and the intervention phase is currently ongoing (ClinicalTrials.gov NCT06376656).
The study is notable for its multidisciplinary scope. Primary outcomes include changes in Montreal Cognitive Assessment scores, EEG and structural MRI brain measures, everyday problem-solving and Iowa Gambling Task performance, and salivary biomarkers (lactoferrin, C-reactive protein, and telomere length). A dedicated economics component will conduct a formal cost-benefit analysis of each intervention package.
For clinicians and health-conscious individuals, the trial addresses a practical question: which intervention — mental engagement, physical exercise, or both together — offers the greatest protection against cognitive decline? If the combined arm proves superior, it would support recommending dual-modality lifestyle programs as standard practice for older adults. The culturally adapted design also strengthens the relevance of findings for Asian populations.
Important caveats apply. This is a protocol paper; no outcome data are yet available. Adherence over a four-year period in older community-dwelling participants may be challenging, and the salivary biomarker measures, while innovative, are not yet standard clinical tools. According to the authors, the first outcome publications are expected in 2026.
Key Findings
- Four-year RCT compares cognitive stimulation, physical activity, and combined intervention in 400 Malaysian adults aged 60+.
- Salivary telomere length, CRP, and lactoferrin are tracked as biological aging markers alongside MRI and EEG.
- Culturally adapted assessments address the gap left by Western-centric cognitive tools in Asian populations.
- A formal cost-benefit economic analysis is embedded in the trial design.
- No outcome data yet — first results expected in 2026 from this ongoing intervention.
Methodology
This is a four-arm randomized controlled trial (cognitive stimulation, physical activity, combined, and control) targeting 400 community-dwelling Malaysian adults aged 60 and older. Outcomes span five disciplinary domains: psychology, neuroscience, decision-making, economics, and biology. Recruitment ran from May 2022 to July 2023, with the intervention phase currently ongoing.
Study Limitations
This is a protocol paper only — no outcome data are available and findings cannot yet be evaluated. Summary is based on the abstract only, as the full text is not open access. A four-year community-based intervention faces real-world adherence challenges that could affect statistical power and interpretation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: